Established Behavioral Health Hospital, New York

$5.0M

SDE

Subscribe Free

Read the full deal writeup

Already a member? Sign in

Full Editorial Writeup

This is an established behavioral health hospital in New York with roughly $5 million in annual cash flow, a professional management team, and a track record the seller describes as consistent revenue and positive earnings. The operation delivers inpatient and/or outpatient mental health and behavioral treatment, a category of care with durable demand regardless of the economic cycle. The listing is being marketed as an opportunity for a qualified investor or strategic partner to participate in the acquisition rather than a simple full buyout, which signals the seller wants capital and possibly operational scale rather than a clean exit.

Behavioral health is one of the most structurally favored niches in healthcare right now. Demand continues to outstrip supply across the US, reimbursement parity rules have strengthened payer coverage for mental health, and licensed inpatient psychiatric capacity is genuinely scarce because new facilities are hard to permit and staff. An operating hospital with existing licensure, accreditation, and payer contracts is a difficult asset to replicate from scratch, which is precisely what makes the going concern valuable.

The practical catch is the near-total absence of disclosed detail. There is no asking price, no revenue, no year founded, and no description of the payer mix, bed count, or staffing model. At $5 million in cash flow this is a lower middle market healthcare deal that will almost certainly command a competitive, multi-buyer process, so a serious buyer needs to move through an NDA quickly and build the full picture before forming any view on value.

Why we like it

Behavioral health hospitals generate durable, recession-resistant earnings because mental health demand does not fall in downturns and is largely funded by insurance, Medicaid, and Medicare rather than discretionary consumer spending. The stated $5 million in cash flow on an established operation with positive earnings history suggests a real, cash-generating asset rather than a story stock.
Licensure, accreditation, and existing payer contracts form a genuine regulatory moat. New inpatient psychiatric capacity is extremely hard to permit, build, and staff, so an operating hospital with these assets in place is far more valuable than the raw economics imply and is nearly impossible to replicate quickly.
The sector enjoys powerful tailwinds: nationwide shortage of behavioral health beds, mental health parity enforcement expanding payer coverage, and consolidation interest from PE-backed platforms. These forces support both current pricing power and a strong eventual exit to a strategic acquirer.
The business already has an experienced management team and established operations, which lowers key-person risk and makes this viable for a capital partner or passive investor rather than only a full-time clinical operator. That management depth is exactly what enables an institutional buyer to underwrite the asset.

How to improve it

Audit the payer mix and renegotiate reimbursement rates with commercial insurers, since even modest rate improvements on inpatient psychiatric days flow almost entirely to the bottom line. Prioritize contracts that are below market relative to peer facilities in the region.
Optimize census and bed utilization by tightening intake and discharge workflows, reducing empty-bed days that are the single biggest profit leak in any inpatient facility. A few points of occupancy gain against fixed overhead compounds directly into cash flow.
Add or expand higher-margin outpatient and partial-hospitalization programs to capture patients across the full continuum of care and smooth revenue. These step-down programs carry lower fixed costs and create a referral feeder back into the inpatient unit.
Address clinical staffing economics by reducing reliance on expensive agency and locum psychiatrists and nurses through better recruiting, retention, and scheduling. Labor is the dominant cost line in behavioral health, so converting contract staff to permanent hires meaningfully improves margins.
Invest in revenue cycle management to cut claim denials and shorten days sales outstanding, since behavioral health claims are notoriously denial-prone. Cleaner billing both raises collected revenue and frees up working capital.
Pursue additional accreditation, program certifications, or specialty service lines (for example adolescent, substance use, or dual-diagnosis units) to open new reimbursement streams and strengthen the facility's position in referral networks.
Build a documented, repeatable operations and compliance playbook to de-risk the asset for a future strategic buyer and position it as a bolt-on for a larger behavioral health platform at a higher multiple.

Diligence notes

Demand the actual revenue figure and full P&L, because a deal advertising $5 million cash flow with no disclosed revenue could carry wildly different margins and valuations. Verify the cash flow definition and whether it reflects owner addbacks, agency staffing normalization, or non-recurring items.
Scrutinize the payer mix and reimbursement concentration, including exposure to Medicaid rate changes and any single commercial payer representing an outsized share of revenue. Behavioral health reimbursement is policy-sensitive, so understand regulatory and rate risk before pricing the deal.
Confirm all state licensure, accreditation (Joint Commission or CARF), and regulatory compliance status, including any open surveys, citations, corrective action plans, or pending investigations. A single compliance failure can suspend admissions and destroy the asset's value.
Clarify the deal structure, since the listing seeks an investor or strategic partner to participate rather than a full buyout. Determine exactly what equity, control, and governance rights are on offer, whether the seller is staying in, and whether real estate is owned or leased.
Investigate the clinical staffing model and dependence on agency or locum providers, since heavy contract labor can mask a fragile cost structure. Review psychiatrist and nurse retention, malpractice history, and any key-person clinical leadership risk.
Assess malpractice, patient safety, and litigation exposure specific to inpatient psychiatric care, including incident history and insurance coverage. This category carries elevated liability risk that must be quantified before closing.

Source

Originally listed on BizBuySell. View original listing →